ID

29298

Descrizione

Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00844714

collegamento

https://clinicaltrials.gov/show/NCT00844714

Keywords

versioni (1)
  1. 16/03/18 16/03/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

16 marzo 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Endothelial Function NCT00844714

Inglese

Eligibility Endothelial Function NCT00844714

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
able and willing to give written informed consent and comply with the requirements of the study protocol
Descrizione

Informed Consent | Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
negative serum pregnancy test (for women of child bearing age)
Descrizione

Childbearing Potential Serum pregnancy test negative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
men and women of reproductive potential must agree to use an acceptable method of birth control during treatment and for twelve months (1 year) after completion of treatment.
Descrizione

Females & males of reproductive potential Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4034483
UMLS CUI [1,2]
C0700589
igg & igm levels within normal limits
Descrizione

Normal IgG levels | Normal IgM levels

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1833177
UMLS CUI [2]
C1855783
adequate renal function as indicated by serum creatinine measurements.
Descrizione

Renal function | Creatinine measurement, serum

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
no previous biological use (investigational or approved) except for the three approved anti-tnf alpha therapies
Descrizione

Biological Factors Absent | Exception Anti-tumor necrosis factor therapy Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005515
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0281481
UMLS CUI [2,3]
C1265611
patients who have been treated with anti-tnf alpha therapies must be off of infliximab and adalimumab for two months before study entry and off of etanercept for one month before study entry
Descrizione

Anti-tumor necrosis factor therapy | Infliximab Discontinued | Adalimumab Discontinued | Etanercept Discontinued

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0281481
UMLS CUI [2,1]
C0666743
UMLS CUI [2,2]
C1444662
UMLS CUI [3,1]
C1122087
UMLS CUI [3,2]
C1444662
UMLS CUI [4,1]
C0717758
UMLS CUI [4,2]
C1444662
no use of phosphodiesterase type 5 inhibitors (pde5) (i.e. sildenafil, tadalafil, and vardenafil) 1 week prior to the study and during the course of the study.
Descrizione

Phosphodiesterase 5 inhibitor Absent | Sildenafil Absent | Tadalafil Absent | Vardenafil Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1318700
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0529793
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1176316
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0971579
UMLS CUI [4,2]
C0332197
sbp ≤ 140/90 for two months prior to study enrollment
Descrizione

Systolic Pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0871470
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior history of mi, cva, cabg, ptca, or peripheral vascular disease
Descrizione

Myocardial Infarction | Cerebrovascular accident | Coronary Artery Bypass Surgery | Percutaneous Transluminal Coronary Angioplasty | Peripheral Vascular Diseases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0010055
UMLS CUI [4]
C2936173
UMLS CUI [5]
C0085096
any serious concomitant medical condition that could interfere with the study.
Descrizione

Comorbidity Interferes with Clinical Trial

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
patients with insulin dependent diabetes
Descrizione

Diabetes Mellitus, Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
failure to provide written consent.
Descrizione

Informed Consent failed

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0231175
individuals with hiv infections
Descrizione

HIV Infections

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019693
sbp > 140/90 at two months prior to study enrollment
Descrizione

Systolic Pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0871470
Ritorna all'inizio della pagina

Similar models

Eligibility Endothelial Function NCT00844714

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent | Protocol Compliance
Item
able and willing to give written informed consent and comply with the requirements of the study protocol
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Childbearing Potential Serum pregnancy test negative
Item
negative serum pregnancy test (for women of child bearing age)
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
Females & males of reproductive potential Contraceptive methods
Item
men and women of reproductive potential must agree to use an acceptable method of birth control during treatment and for twelve months (1 year) after completion of treatment.
boolean
C4034483 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Normal IgG levels | Normal IgM levels
Item
igg & igm levels within normal limits
boolean
C1833177 (UMLS CUI [1])
C1855783 (UMLS CUI [2])
Renal function | Creatinine measurement, serum
Item
adequate renal function as indicated by serum creatinine measurements.
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Biological Factors Absent | Exception Anti-tumor necrosis factor therapy Quantity
Item
no previous biological use (investigational or approved) except for the three approved anti-tnf alpha therapies
boolean
C0005515 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0281481 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Anti-tumor necrosis factor therapy | Infliximab Discontinued | Adalimumab Discontinued | Etanercept Discontinued
Item
patients who have been treated with anti-tnf alpha therapies must be off of infliximab and adalimumab for two months before study entry and off of etanercept for one month before study entry
boolean
C0281481 (UMLS CUI [1])
C0666743 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1122087 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0717758 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
Phosphodiesterase 5 inhibitor Absent | Sildenafil Absent | Tadalafil Absent | Vardenafil Absent
Item
no use of phosphodiesterase type 5 inhibitors (pde5) (i.e. sildenafil, tadalafil, and vardenafil) 1 week prior to the study and during the course of the study.
boolean
C1318700 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0529793 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1176316 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0971579 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Systolic Pressure
Item
sbp ≤ 140/90 for two months prior to study enrollment
boolean
C0871470 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Myocardial Infarction | Cerebrovascular accident | Coronary Artery Bypass Surgery | Percutaneous Transluminal Coronary Angioplasty | Peripheral Vascular Diseases
Item
prior history of mi, cva, cabg, ptca, or peripheral vascular disease
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
C2936173 (UMLS CUI [4])
C0085096 (UMLS CUI [5])
Comorbidity Interferes with Clinical Trial
Item
any serious concomitant medical condition that could interfere with the study.
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Diabetes Mellitus, Insulin-Dependent
Item
patients with insulin dependent diabetes
boolean
C0011854 (UMLS CUI [1])
Informed Consent failed
Item
failure to provide written consent.
boolean
C0021430 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
HIV Infections
Item
individuals with hiv infections
boolean
C0019693 (UMLS CUI [1])
Systolic Pressure
Item
sbp > 140/90 at two months prior to study enrollment
boolean
C0871470 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial